Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The rs61764370 Functional Variant in the KRAS Oncogene is Associated with Chronic Myeloid Leukemia Risk in Women.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2016

Gutiérrez-Malacatt Humberto, Ayala-Sanchez Manuel, Aquino-Ortega Xochitl, Dominguez-Rodriguez Jacqueline, Martinez-Tovar Adolfo, Olarte-Carrillo Irma, Martinez-Hernandez Angelica, C Cecilia Contreras-Cubas, Orozco Lorena, Cordova Emilio J

Abstract excerpt

BACKGROUND: Chronic myeloid leukemia (CML) is one of the most frequent hematopoietic malignancies in the elderly population; however, knowledge is limited regarding the genetic factors associated with increased risk for CML. Polymorphisms affecting microRNA (miRNA) biogenesis or mRNA:miRNA interactions are important risk factors in the development of different types of cancer. Thus, we carried out a case-control...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3' Untranslated Regions
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to MicroRNAs

Share to Neoplasm Staging

Share to Prognosis

Share to Proto-Oncogene Proteins p21(ras)

Source

Identifiers

PMID: 27221928
DOI: 10.7314/apjcp.2016.17.4.2265

Genes

KRAS
AGO1
BRCA1
GEMIN4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The rs61764370 Functional Variant in the KRAS Oncogene is Associated with Chronic Myeloid Leukemia Risk in Women.PMID 27221928Read ↗

Gene Variants in Components of the microRNA Processing Pathway in Chronic Myeloid Leukemia.Semantic proximity Read ↗

MTHFR genetic polymorphisms may contribute to the risk of chronic myelogenous leukemia in adults: a meta-analysis of 12 genetic association studies.Semantic proximity Read ↗

Update meta-analysis from biomedical literature about MTHFR'polymorphisms and the CML' risk.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase gene polymorphisms contribute to acute myeloid leukemia and chronic myeloid leukemia susceptibilities: evidence from meta-analyses.Semantic proximity Read ↗

Polymorphisms in the CYP2A6 and ABCC4 genes are associated with a protective effect on chronic myeloid leukemia in the Brazilian Amazon population.Semantic proximity Read ↗

MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects.Semantic proximity Read ↗

Polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR) are associated with susceptibility to adult acute myeloid leukemia in a Chinese population.Semantic proximity Read ↗

Rs4846049 Polymorphism at the 3'-UTR of MTHFR Gene: Association with Susceptibility to Childhood Acute Lymphoblastic Leukemia.Semantic proximity Read ↗

Significance of ATM Gene Polymorphisms in Chronic Myeloid Leukemia - a Case Control Study from India.Semantic proximity Read ↗

MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case-control study in Korea.Semantic proximity Read ↗

Impact of Methionine Synthase Reductase Polymorphisms in Chronic Myeloid Leukemia Patients.Semantic proximity Read ↗

Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.